Dry AMD is a leading cause of blindness impacting more than 5 million people in the US alone, which can severely impair visual function. We are studying the role of mitochondria in certain retinal diseases like #DryAMD. Check out this video to learn more: https://bit.ly/4k2l0Do
People with dry AMD experience declining visual function, including blurred vision and difficulty seeing details particularly in low light. At Stealth, we are conducting a clinical study for a treatment in dry AMD.
Learn more at https://bit.ly/4gCGaoI #AMDAwarenessMonth2025
Happening today the @BascomPalmerEye 2025 Angiogenesis, Exudation, and Degeneration Virtual Meeting, we are excited to share new analyses from our Phase 2 ReCLAIM-2 trial in dry age-related macular degeneration (dAMD). #dryAMD https://bit.ly/3Cwil4h
It's #AMDAwarenessMonth2025! DYK nearly 20 million Americans aged 40+ have been diagnosed with a form of macular degeneration? Follow along with the American Macular Degeneration Foundation this month to learn about early detection, risk reduction, impact on daily living & more.
You are about to enter a third-party website that is not owned or controlled by
Mighty Therapeutics. We are not responsible for the content, security, or
privacy practices of any third-party website.